Correlation Between VTv Therapeutics and Nextcom

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both VTv Therapeutics and Nextcom at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining VTv Therapeutics and Nextcom into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between vTv Therapeutics and Nextcom, you can compare the effects of market volatilities on VTv Therapeutics and Nextcom and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in VTv Therapeutics with a short position of Nextcom. Check out your portfolio center. Please also check ongoing floating volatility patterns of VTv Therapeutics and Nextcom.

Diversification Opportunities for VTv Therapeutics and Nextcom

0.69
  Correlation Coefficient

Poor diversification

The 3 months correlation between VTv and Nextcom is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding vTv Therapeutics and Nextcom in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nextcom and VTv Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on vTv Therapeutics are associated (or correlated) with Nextcom. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nextcom has no effect on the direction of VTv Therapeutics i.e., VTv Therapeutics and Nextcom go up and down completely randomly.

Pair Corralation between VTv Therapeutics and Nextcom

Given the investment horizon of 90 days vTv Therapeutics is expected to generate 1.51 times more return on investment than Nextcom. However, VTv Therapeutics is 1.51 times more volatile than Nextcom. It trades about 0.25 of its potential returns per unit of risk. Nextcom is currently generating about 0.0 per unit of risk. If you would invest  2,159  in vTv Therapeutics on January 25, 2024 and sell it today you would earn a total of  339.00  from holding vTv Therapeutics or generate 15.7% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy77.27%
ValuesDaily Returns

vTv Therapeutics  vs.  Nextcom

 Performance 
       Timeline  
vTv Therapeutics 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in vTv Therapeutics are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, VTv Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.
Nextcom 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Nextcom are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Nextcom may actually be approaching a critical reversion point that can send shares even higher in May 2024.

VTv Therapeutics and Nextcom Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with VTv Therapeutics and Nextcom

The main advantage of trading using opposite VTv Therapeutics and Nextcom positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if VTv Therapeutics position performs unexpectedly, Nextcom can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nextcom will offset losses from the drop in Nextcom's long position.
The idea behind vTv Therapeutics and Nextcom pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Other Complementary Tools

Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.